The Ministry of Corporate Affairs, Government of India ("MCA"), has approved change of name of the Company from "Suven Pharmaceuticals Limited" to "Cohance Lifesciences Limited", with effect from May 7, 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.
The Company would make necessary application to the BSE Limited and the National Stock Exchange of India Limited for effecting change of name of the Company in due course. We further inform that the Name Clause of the Memorandum of Association of the Company stands altered accordingly, and the name "Suven Pharmaceuticals Limited" wherever it appears in the Memorandum of Association and the Articles of Association, gets replaced with the new name "Cohance Lifesciences Limited".
Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 1118.50 as compared to the previous close of Rs. 1148.90. The total number of shares traded during the day was 2205 in over 301 trades.
The stock hit an intraday high of Rs. 1147.30 and intraday low of 1103.80. The net turnover during the day was Rs. 2478216.00.